{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":876,"total_is_capped":false,"direct_labels_cover":4,"predictions_cover":876,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"b064781980c7","filters":{"topic":"Biosimilars and Bioanalytical Methods"}},"results":[{"id":"W1515542254","doi":"10.1023/a:1007669411738","title":"Bioanalytical Method Validation—A Revisit with a Decade of Progress","year":2000,"lang":"en","type":"article","venue":"Pharmaceutical Research","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1571,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Purdue Pharma (Canada); University of Saskatchewan","funders":"","keywords":"Bioanalysis; Data science; Computer science; Computational biology; Nanotechnology; Biochemical engineering; Engineering ethics; Biology; Engineering; Materials science","retraction":null,"screen_n_in":null,"score":{"opus":0.1704924968469756,"gpt":0.5186894285672768,"spread":0.3481969317203012,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003792299,0.0001748989,0.0004143005,0.0001981449,0.0001672203,0.00003129094,0.0004418785,0.0002690845,0.02401789],"category_scores_gemma":[0.0004006419,0.000114699,0.0001169844,0.001014595,0.00166373,0.00007210963,0.0001128305,0.001085386,0.0004594686],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003963213,"about_ca_system_score_gemma":0.00011845,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001377542,"about_ca_topic_score_gemma":9.14723e-7,"domain_scores_codex":[0.996249,0.001740445,0.0004086194,0.0004883847,0.0003017256,0.0008118228],"domain_scores_gemma":[0.9975392,0.00151202,0.00003659852,0.0003713208,0.000382692,0.0001582231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003415045,0.001147942,0.005621872,0.0002325972,0.0007445969,0.00004973591,0.0001249313,0.000003717601,0.0541993,0.01896342,0.006255664,0.9092412],"study_design_scores_gemma":[0.001728992,0.0006483043,0.001416932,0.0001089198,0.0001920006,0.00009333713,0.00005532384,0.0005703649,0.5946772,0.00119003,0.3990651,0.0002534979],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5000344,0.05729895,0.02821009,0.1101796,0.0007020214,0.007987886,0.0004577732,0.0008053263,0.2943239],"genre_scores_gemma":[0.9450496,0.0006183241,0.04062925,0.0004592605,0.00009762941,0.0000688241,0.00001840417,0.0000419619,0.01301677],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9089877,"threshold_uncertainty_score":0.9768743,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4291020097","doi":"10.1126/scitranslmed.abo7793","title":"The past, present, and future of antibiotics","year":2022,"lang":"en","type":"review","venue":"Science Translational Medicine","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":616,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Antibiotics; Risk analysis (engineering); Intensive care medicine; Business; Reimbursement; Investment (military); Medicine; Political science; Biology; Health care; Economic growth; Economics","retraction":null,"screen_n_in":null,"score":{"opus":0.07061422966179243,"gpt":0.3852018712682873,"spread":0.3145876416064948,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.001599717,0.0001535,0.0005723814,0.0001284385,0.0004451248,0.000006426409,0.0004437355,0.0001091145,0.0006754689],"category_scores_gemma":[0.0000464191,0.0000724061,0.00009278132,0.0006752781,0.003947249,0.00003194745,0.00005860522,0.0003835421,0.000002034795],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001084696,"about_ca_system_score_gemma":0.0002171042,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004197128,"about_ca_topic_score_gemma":7.119958e-7,"domain_scores_codex":[0.9987333,0.000207052,0.000403597,0.0002763478,0.0001649767,0.0002147607],"domain_scores_gemma":[0.9985017,0.001038058,0.0001731904,0.0002076562,0.00005023752,0.00002912323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000005320599,0.00001157977,0.000008758224,0.0004655981,0.00004422932,4.973122e-7,0.00003639479,2.754878e-8,0.0000376576,0.006479651,0.0009692992,0.991941],"study_design_scores_gemma":[0.0001390057,0.00009108242,0.0001150723,0.0003254545,0.000269636,0.00004271487,0.00005455258,0.000001593721,0.00000742827,0.0004670619,0.9984099,0.00007648581],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[7.667765e-7,0.990383,0.00002793828,0.006364465,0.0009922106,0.0002347104,0.00004516599,0.000006596645,0.001945157],"genre_scores_gemma":[0.00001803187,0.9988821,0.0002016219,0.00004125074,0.0004402407,0.000001108817,0.00002454325,0.000005837108,0.0003852459],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9974406,"threshold_uncertainty_score":0.9987634,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2132071446","doi":"10.1023/b:pham.0000003390.51761.3d","title":"Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of Macromolecules","year":2003,"lang":"en","type":"article","venue":"Pharmaceutical Research","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":614,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Greenfield Research (Canada)","funders":"American Association of Pharmaceutical Scientists; Eli Lilly and Company","keywords":"Bioanalysis; Acceptance testing; Computer science; Process (computing); Biochemical engineering; Computational biology; Chemistry; Engineering; Chromatography; Biology; Software engineering","retraction":null,"screen_n_in":null,"score":{"opus":0.3516081189835731,"gpt":0.574760009449789,"spread":0.2231518904662159,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008468363,0.0001511158,0.0003502316,0.0002705216,0.0002284752,0.00002398202,0.0004280935,0.0001676138,0.002154412],"category_scores_gemma":[0.002564372,0.0001042282,0.0001803491,0.0008081951,0.0004156207,0.00004818124,0.0001592732,0.0005783016,0.0000473475],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005461209,"about_ca_system_score_gemma":0.0001491152,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001059644,"about_ca_topic_score_gemma":7.808673e-7,"domain_scores_codex":[0.9965037,0.001682544,0.0005862396,0.0003610156,0.0002325111,0.000634034],"domain_scores_gemma":[0.9925681,0.006407159,0.00008669472,0.0002838564,0.0005387716,0.0001153663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003576154,0.000451612,0.0004527321,0.0000973741,0.0004730515,0.000001260679,0.0000625044,0.000008838871,0.917374,0.018922,0.01138845,0.05041054],"study_design_scores_gemma":[0.0008877222,0.0004045913,0.00005262453,0.00002354336,0.0002060042,0.000008348428,0.0001603322,0.0004460244,0.852,0.0009904641,0.1447227,0.00009766746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.07346676,0.002172889,0.8162317,0.06716467,0.002715526,0.007828717,0.001471188,0.000111365,0.02883721],"genre_scores_gemma":[0.9557057,0.0001909786,0.04157087,0.0004195175,0.00003147298,0.0001327939,0.00002729969,0.0000250697,0.00189629],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.8822389,"threshold_uncertainty_score":0.9987578,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2031889731","doi":"10.1056/nejmoa040528","title":"Pure Red-Cell Aplasia and Epoetin Therapy","year":2004,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":432,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hotel Dieu Hospital","funders":"National Cancer Institute; Amgen","keywords":"Pure red cell aplasia; Medicine; Epoetin alfa; Aplasia; Erythropoietin; Incidence (geometry); Anemia; Surgery; Gastroenterology; Red Cell; Pediatrics; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01967450259997798,"gpt":0.2759597915158539,"spread":0.2562852889158759,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008111037,0.0001157259,0.000341946,0.00008662816,0.00004987933,0.000004857788,0.0001129822,0.0001531764,0.0005493476],"category_scores_gemma":[0.0001736805,0.00006238274,0.00004845546,0.00008225867,0.0002080964,0.00003553776,0.00001495966,0.0004366546,0.000005284649],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001254176,"about_ca_system_score_gemma":0.00006013513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001913052,"about_ca_topic_score_gemma":0.000005284772,"domain_scores_codex":[0.9992144,0.0001294154,0.000336024,0.0001005021,0.00005700567,0.0001627126],"domain_scores_gemma":[0.9994042,0.0001713727,0.0001822739,0.00009091299,0.00007071676,0.00008054147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001532991,0.0001583899,0.002390262,0.00002077164,0.000213804,0.000219129,0.001144583,0.000003577124,0.4673392,0.0007600019,0.02815436,0.4980629],"study_design_scores_gemma":[0.1046109,0.005201983,0.007321343,0.0002822907,0.0001592523,0.00557071,0.0003313429,4.504773e-7,0.0797298,0.01221658,0.7843783,0.0001969726],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8327084,0.0671555,0.001361029,0.09187605,0.00183723,0.0001417569,0.000003186744,0.00001845588,0.004898381],"genre_scores_gemma":[0.9894038,0.005270085,0.001690347,0.001503356,0.000954339,2.308313e-7,0.000001694831,0.000008762706,0.001167392],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.756224,"threshold_uncertainty_score":0.6014971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2046974419","doi":"10.1208/s12248-014-9599-2","title":"Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides—Harmonized Terminology and Tactical Recommendations","year":2014,"lang":"en","type":"article","venue":"The AAPS Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":339,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Canada","funders":"European Commission; European Federation of Pharmaceutical Industries and Associations; American Association of Pharmaceutical Scientists","keywords":"Immunogenicity; Terminology; Medicine; Clinical trial; Biosimilar; Pharmacology; Immunology; Pathology; Internal medicine; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.1269396769028942,"gpt":0.424687664878984,"spread":0.2977479879760898,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004470032,0.00008975089,0.0003834834,0.00002574159,0.0002626586,0.00001532357,0.0001385142,0.0001450092,0.00005773463],"category_scores_gemma":[0.0009569918,0.00004231294,0.00009322672,0.00005090129,0.0009999857,0.00003318427,0.0001760845,0.0006594971,2.479026e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000721987,"about_ca_system_score_gemma":0.00005222105,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001113611,"about_ca_topic_score_gemma":0.000003228827,"domain_scores_codex":[0.9972512,0.001418484,0.001015678,0.0001278825,0.00003554446,0.0001512046],"domain_scores_gemma":[0.9976634,0.0008755763,0.001152394,0.0002045032,0.00008017,0.00002396426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0002847576,0.0002399413,0.2053496,0.00003340555,0.0007630044,0.0000017768,0.0002800637,1.434237e-7,0.4636185,0.005566858,0.0001836138,0.3236783],"study_design_scores_gemma":[0.001693948,0.0006562814,0.9581638,0.00007982172,0.0004001868,0.001888683,0.0002355596,0.00009261626,0.02215756,0.01041753,0.004102653,0.0001113785],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886723,0.001207206,0.001141149,0.008374824,0.0002184341,0.0001633909,0.000003776039,0.000003847674,0.0002150604],"genre_scores_gemma":[0.9957203,0.0006163755,0.003255317,0.0002869141,0.00002983346,0.000002047337,4.024252e-7,0.000004755882,0.00008402183],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7528142,"threshold_uncertainty_score":0.3684489,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230666570","doi":"10.4103/1947-2714.128482","title":"Western blot: Technique, theory and trouble shooting","year":2014,"lang":"en","type":"article","venue":"North American Journal of Medical Sciences","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":230,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Trouble shooting; Medicine; Data science; Computer science; Engineering","retraction":null,"screen_n_in":null,"score":{"opus":0.02028156467244222,"gpt":0.3222389567106703,"spread":0.301957392038228,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.007346627,0.0000895113,0.0003103453,0.00008534919,0.000144876,0.00001963325,0.0004129681,0.00007251299,0.0002998298],"category_scores_gemma":[0.0009764671,0.00005073427,0.00006025334,0.0003086937,0.002752411,0.00007546223,0.00007984733,0.0004402729,0.000004624219],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007016218,"about_ca_system_score_gemma":0.00007993708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001939888,"about_ca_topic_score_gemma":0.00002267456,"domain_scores_codex":[0.9983467,0.0006866866,0.0003267791,0.0001294493,0.0002144813,0.0002959006],"domain_scores_gemma":[0.9986345,0.000845061,0.0002731821,0.00006336704,0.00003534312,0.0001485773],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00005186444,0.00006138389,0.2733549,0.000005411485,0.00003760368,0.000004645728,0.00009179976,3.572163e-7,0.001010168,0.002062246,0.0001601834,0.7231595],"study_design_scores_gemma":[0.003230473,0.01527442,0.7264746,0.0005861112,0.0004904797,0.006762523,0.002955039,0.00009456041,0.02180623,0.00675605,0.2143924,0.001177092],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9649871,0.001366784,0.02625998,0.006278059,0.000343534,0.00005292088,0.000001263158,0.00001425965,0.0006961327],"genre_scores_gemma":[0.994716,0.0001282062,0.003812727,0.001167203,0.0001169496,8.951999e-7,1.586956e-7,0.000003102086,0.00005479349],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7219824,"threshold_uncertainty_score":0.9999616,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2036463891","doi":"10.1111/j.1537-2995.2008.01749.x","title":"Epoetin‐associated pure red cell aplasia: past, present, and future considerations","year":2008,"lang":"en","type":"review","venue":"Transfusion","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":188,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McGill University Health Centre; Hotel Dieu Hospital","funders":"National Cancer Institute; Johnson and Johnson; Amgen","keywords":"Pure red cell aplasia; Medicine; Epoetin alfa; Erythropoietin; Hemodialysis; Darbepoetin alfa; Anemia; Etiology; Internal medicine; Food and drug administration; Intensive care medicine; Surgery; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.0363049522753764,"gpt":0.3013012127299262,"spread":0.2649962604545498,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000190532,0.0004621953,0.001395424,0.0001263616,0.0004087937,0.0000234481,0.0001310211,0.001840575,0.001172756],"category_scores_gemma":[0.00002208951,0.0003285106,0.0004319356,0.0002211881,0.0002509792,0.00003794835,0.0000479144,0.001014657,0.00005211473],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003289829,"about_ca_system_score_gemma":0.0001066307,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001240019,"about_ca_topic_score_gemma":0.00001408926,"domain_scores_codex":[0.9975544,0.0008712337,0.000577713,0.0005646587,0.00005485531,0.000377101],"domain_scores_gemma":[0.9989382,0.0004527905,0.0001871883,0.0002975808,0.00006719005,0.00005707496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003034525,0.0003499275,0.00001122804,0.002160144,0.0005129739,0.00006668249,0.0001566229,3.930421e-8,0.0004802371,0.0001745309,0.1551049,0.8409523],"study_design_scores_gemma":[0.0006170656,0.0001217216,0.00002230304,0.000783427,0.0008466849,0.0003825612,0.00001916417,3.582732e-7,0.0001191567,0.00008421177,0.996668,0.0003352755],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001221884,0.9922418,0.00002927609,0.001893272,0.0006840695,0.0007920408,0.0002307264,0.0000860248,0.004030583],"genre_scores_gemma":[0.00001360516,0.9960748,0.0002681231,0.00009642167,0.0004249813,0.0000363205,0.0003242435,0.00003829258,0.002723234],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8415632,"threshold_uncertainty_score":0.9999167,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2623521568","doi":"10.1136/annrheumdis-2016-210459","title":"Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":186,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"Amgen","keywords":"Adalimumab; Medicine; Rheumatoid arthritis; Clinical endpoint; Internal medicine; Adverse effect; Bioequivalence; Pharmacokinetics; Gastroenterology; Randomized controlled trial","retraction":null,"screen_n_in":null,"score":{"opus":0.04817295763684427,"gpt":0.3298317602822459,"spread":0.2816588026454016,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004728189,0.0002737736,0.0008401393,0.00006441187,0.0004200886,0.00004917543,0.0007771989,0.00007733958,0.00005764285],"category_scores_gemma":[0.000289148,0.0001316971,0.0001218228,0.000161184,0.0007523947,0.000133615,0.0003698056,0.0001606603,0.000001597809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008738381,"about_ca_system_score_gemma":0.00008863415,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001335154,"about_ca_topic_score_gemma":0.0001092484,"domain_scores_codex":[0.9980921,0.0004343373,0.0006365097,0.0003364708,0.0001734892,0.0003271017],"domain_scores_gemma":[0.9977791,0.0003032514,0.000595966,0.001053461,0.0001948661,0.00007336909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8025352,0.01161907,0.146475,0.0003329455,0.002616544,0.000004426699,0.002239121,0.0003685211,0.000171693,0.0001987595,0.000886246,0.03255238],"study_design_scores_gemma":[0.4572364,0.001873336,0.5299529,0.004701073,0.0003077409,0.000006915646,0.0006436403,0.00006926011,0.004459323,0.0002564355,0.00004324521,0.0004497185],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946144,0.001138724,0.00003183977,0.0009839928,0.00008334414,0.002859695,0.0002108428,0.00001084654,0.00006627565],"genre_scores_gemma":[0.9993244,0.0003062895,0.00006432802,0.0001686663,0.000002382783,0.00006520579,0.000005867579,0.00001524626,0.00004758706],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3834779,"threshold_uncertainty_score":0.5370452,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1964595219","doi":"10.1208/s12248-014-9685-5","title":"Recommendations for Validation of LC-MS/MS Bioanalytical Methods for Protein Biotherapeutics","year":2014,"lang":"en","type":"article","venue":"The AAPS Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":174,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BioPhage Pharma (Canada)","funders":"Genentech; Biogen; GlaxoSmithKline; Pfizer; Novartis Institutes for BioMedical Research; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Bioanalysis; Chemistry; Liquid chromatography–mass spectrometry; Chromatography; Context (archaeology); Harmonization; Biochemical engineering; Computational biology; Mass spectrometry; Engineering; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.08423505718237441,"gpt":0.4061848771733993,"spread":0.3219498199910249,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00413319,0.0001278148,0.0002965878,0.00008723243,0.0003284474,0.00003129979,0.0002973929,0.0002038057,0.0003757619],"category_scores_gemma":[0.0007576872,0.00007503819,0.0002619464,0.0001328067,0.0002517304,0.00004884785,0.00003314623,0.0002808115,0.000005583703],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002344979,"about_ca_system_score_gemma":0.00004450024,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003673906,"about_ca_topic_score_gemma":0.00000117891,"domain_scores_codex":[0.9982256,0.0008391471,0.0004824432,0.0001451753,0.00003143064,0.0002761636],"domain_scores_gemma":[0.9981042,0.001105649,0.000289829,0.000226591,0.0002418861,0.00003189646],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003943079,0.0001889474,0.00004845616,0.00003943954,0.000591798,4.567536e-8,0.0001384,0.00000361832,0.668698,0.03153661,0.007437995,0.2909224],"study_design_scores_gemma":[0.001010752,0.0005652182,0.00005757111,0.00003388279,0.000273156,0.00003593363,0.00005124466,0.0006527745,0.4885936,0.04453276,0.4640806,0.0001125594],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.00246981,0.0005122479,0.9699472,0.02549789,0.0005943921,0.0005633387,0.00004878204,0.00001563183,0.0003507173],"genre_scores_gemma":[0.1064446,0.0001541286,0.8876615,0.001631963,0.0004790135,0.00007556201,0.00004247408,0.00004372085,0.00346711],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.4566426,"threshold_uncertainty_score":0.411433,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2742486699","doi":"10.1007/s11523-017-0518-1","title":"Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars","year":2017,"lang":"en","type":"review","venue":"Targeted Oncology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":171,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital","funders":"Pfizer","keywords":"Bevacizumab; Biosimilar; Medicine; Colorectal cancer; Oncology; Intensive care medicine; Internal medicine; Cancer; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.06030926735329518,"gpt":0.4066597918623675,"spread":0.3463505245090723,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007954383,0.000432629,0.003116016,0.000302792,0.00009957594,0.000009956168,0.0004468397,0.001134942,0.0002242005],"category_scores_gemma":[0.0001548592,0.0002431739,0.0004101666,0.0001810067,0.001310551,0.00002741191,0.0002125662,0.0008149238,0.0000112032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004146558,"about_ca_system_score_gemma":0.0006837382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005726122,"about_ca_topic_score_gemma":0.00143305,"domain_scores_codex":[0.9962395,0.001814013,0.0009208226,0.0005057344,0.00003289021,0.0004869903],"domain_scores_gemma":[0.9983274,0.0006273214,0.00065721,0.0003188004,0.00003759631,0.0000316527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003999412,0.0003169263,0.00008070187,0.000518531,0.0003297064,0.00001720304,0.0001093579,3.702394e-7,0.0001441257,0.0001808351,0.0001550254,0.9977473],"study_design_scores_gemma":[0.004676242,0.0004991791,0.0003203712,0.001152174,0.0009647781,0.00006897802,0.0000390077,0.000009159635,0.0001683835,0.0003058192,0.9915407,0.0002551556],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005877764,0.9961729,0.000001723738,0.0003976066,0.001092621,0.001152339,0.0002527379,0.00001045667,0.0003318381],"genre_scores_gemma":[0.002019324,0.9973257,0.00006265904,0.0000296674,0.00005296958,0.0003153539,0.00007190747,0.00002086662,0.0001015177],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9974921,"threshold_uncertainty_score":0.9916342,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2080183440","doi":"10.4155/bio.13.38","title":"Bioanalysis of Antibody–Drug Conjugates: American Association of Pharmaceutical Scientists Antibody–Drug Conjugate Working Group Position Paper","year":2013,"lang":"en","type":"article","venue":"Bioanalysis","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":165,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Bell (Canada)","funders":"","keywords":"Bioanalysis; Antibody-drug conjugate; Conjugate; Drug; Linker; Pharmacology; Pharmaceutical industry; Computational biology; Chemistry; Computer science; Combinatorial chemistry; Antibody; Medicine; Monoclonal antibody; Biology; Chromatography; Mathematics; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.01267553105416273,"gpt":0.3085342130447143,"spread":0.2958586819905516,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00182117,0.0004058172,0.001420229,0.0007225683,0.000230372,0.00007204554,0.0005019174,0.0002569735,0.003082624],"category_scores_gemma":[0.0003164337,0.0003323694,0.0009170427,0.00254041,0.001237793,0.0002609452,0.0001811998,0.0003985611,0.0001536277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001476237,"about_ca_system_score_gemma":0.00005818487,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001914233,"about_ca_topic_score_gemma":0.0001576537,"domain_scores_codex":[0.9957928,0.001089615,0.001325966,0.0007478321,0.0003249881,0.0007187994],"domain_scores_gemma":[0.9966903,0.000690017,0.001319598,0.0005684934,0.0006100942,0.0001215029],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009518872,0.0005029348,0.158004,0.00006821934,0.004098837,0.000003677109,0.0001148514,0.000006225408,0.818183,0.0006887761,0.0008135164,0.01742073],"study_design_scores_gemma":[0.004749166,0.0005189527,0.2333771,0.0005654065,0.01646901,0.00002899797,0.001852264,0.003739375,0.6863939,0.001171351,0.04900842,0.002126086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9731483,0.01283038,0.002678004,0.007116344,0.0008318179,0.0007045973,0.0003209336,0.0001426698,0.002226883],"genre_scores_gemma":[0.9936143,0.001355821,0.002485796,0.0005958081,0.0000513864,0.00001324342,0.0003191248,0.00002677452,0.001537748],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1317892,"threshold_uncertainty_score":0.9999129,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2010222138","doi":"10.1007/s00216-011-5655-2","title":"Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer","year":2012,"lang":"en","type":"article","venue":"Analytical and Bioanalytical Chemistry","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":157,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Chemistry; Chromatography; Orbitrap; Mass spectrometry; Analyte; Sample preparation","retraction":null,"screen_n_in":null,"score":{"opus":0.01288139348029114,"gpt":0.2720874130105445,"spread":0.2592060195302534,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008110479,0.0003037474,0.0009237846,0.0001144648,0.0000489978,0.00001295419,0.0001536257,0.000543663,0.000204513],"category_scores_gemma":[0.0005326753,0.0002427965,0.0003031196,0.0003878327,0.0007956924,0.00009129827,0.00006527906,0.0003573181,0.000002076078],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003560378,"about_ca_system_score_gemma":0.00003915321,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002842867,"about_ca_topic_score_gemma":0.000002550198,"domain_scores_codex":[0.9977882,0.0001199085,0.0008504068,0.0004396441,0.0001260644,0.000675761],"domain_scores_gemma":[0.9983011,0.0009295248,0.0002182419,0.000230973,0.0001760385,0.0001440733],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004663648,0.0007518518,0.006738939,0.0003770548,0.000465319,0.000002989263,0.00009510574,9.150592e-8,0.9860771,0.002476814,0.00008873402,0.002459618],"study_design_scores_gemma":[0.002428315,0.0001920682,0.002555879,0.0001344071,0.000937874,0.00002039284,0.0002321892,0.001751933,0.9902722,0.0006946456,0.0004321027,0.0003479779],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837673,0.001584312,0.008827861,0.001400188,0.0001125486,0.0006669734,0.0005153304,0.0000377404,0.003087701],"genre_scores_gemma":[0.9962878,0.00005808493,0.002694515,0.0001284163,0.00005905716,0.00001225737,0.00007506555,0.00001593152,0.0006689273],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0125204,"threshold_uncertainty_score":0.9900955,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2593485868","doi":"10.1007/s40265-017-0717-1","title":"The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":153,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Health Canada; Pfizer","keywords":"Biosimilar; Medicine; Clinical trial; Terminology; Risk analysis (engineering); Intensive care medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.09806852305771535,"gpt":0.3684910117220404,"spread":0.270422488664325,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008183816,0.0002173378,0.0008114494,0.00007114199,0.0003663549,0.00003441683,0.0004155644,0.0006207761,0.00006524892],"category_scores_gemma":[0.0002889495,0.0001247619,0.0002518783,0.00007312236,0.000834646,0.00002639154,0.0001171355,0.0004328089,0.00004798506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001757473,"about_ca_system_score_gemma":0.0001188729,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009177495,"about_ca_topic_score_gemma":0.000005951569,"domain_scores_codex":[0.9986157,0.0004306995,0.0004397434,0.0002733236,0.00003517806,0.0002052896],"domain_scores_gemma":[0.9980306,0.00060542,0.0004761947,0.0008134845,0.0000527817,0.0000214997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000003877623,0.00002328377,0.000001470971,0.001066021,0.0002544672,0.000001191238,0.00006793334,4.696692e-10,0.00003637059,0.01666379,0.006880315,0.9750013],"study_design_scores_gemma":[0.0001070642,0.00002077142,0.00002903302,0.001265257,0.000540268,0.0000273003,0.00008727413,4.840831e-8,0.0001967208,0.0007907465,0.9967913,0.0001442271],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000004427111,0.9940158,0.000004084226,0.0003177706,0.0002956577,0.0002538478,0.0001512679,0.00001996467,0.004937224],"genre_scores_gemma":[0.00006595623,0.9975688,0.0001619685,0.00007583801,0.00003985632,0.00002414963,0.00007856531,0.00001787732,0.001967032],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.989911,"threshold_uncertainty_score":0.5087642,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1980282196","doi":"10.1016/j.biologicals.2014.05.005","title":"The challenge of indication extrapolation for infliximab biosimilars","year":2014,"lang":"en","type":"review","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":148,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Western University; University of British Columbia; University of Toronto; University of Calgary; University of Alberta; Robarts Clinical Trials; Université de Montréal","funders":"Genentech; Celltrion; UCB; LEO Pharma; Ironwood Pharmaceuticals, Incorporated; Teva Pharmaceutical Industries; Gilead Sciences; ActoGeniX; Sanofi; Celgene; Biogen; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Biosimilar; Infliximab; Medicine; Extrapolation; Pharmacology; Internal medicine; Mathematics; Tumor necrosis factor alpha; Statistics","retraction":null,"screen_n_in":null,"score":{"opus":0.1216315824002214,"gpt":0.4075227525799325,"spread":0.2858911701797111,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001746658,0.0003213281,0.001448067,0.00008839345,0.0002112314,0.00001369504,0.000533536,0.001492889,0.0001215111],"category_scores_gemma":[0.001077321,0.0001471799,0.0006993801,0.0001698857,0.0005444093,0.00001607951,0.00009476535,0.0003179532,0.00003960123],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000271287,"about_ca_system_score_gemma":0.00005788348,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":7.240483e-7,"about_ca_topic_score_gemma":0.000001142045,"domain_scores_codex":[0.9973971,0.0008431506,0.0009626529,0.0004216763,0.00003289187,0.0003425332],"domain_scores_gemma":[0.9954501,0.003076104,0.0008953501,0.0004607074,0.00009509241,0.00002260678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002320538,0.00005478681,0.000001663937,0.001104655,0.0002285342,5.578702e-8,0.000004619934,1.091824e-8,0.00008380033,0.008323904,0.001966124,0.9882087],"study_design_scores_gemma":[0.0001947267,0.0003956761,0.00001172246,0.0006938431,0.000405814,0.000003296011,0.000003747744,0.00000114435,0.0001125452,0.002466397,0.9955156,0.0001954554],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001292243,0.9961721,0.0008837747,0.0005294189,0.0004332872,0.001134565,0.0001831884,0.00003557371,0.0006267602],"genre_scores_gemma":[0.0001199725,0.9983253,0.0005366821,0.00009434199,0.00009106662,0.0002471995,0.0002372153,0.00001656682,0.0003316743],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9935495,"threshold_uncertainty_score":0.9998034,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2593211227","doi":"10.1016/j.jaad.2016.12.014","title":"Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":137,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SKiN Health; Probity Medical Research","funders":"","keywords":"Adalimumab; Medicine; Psoriasis Area and Severity Index; Clinical endpoint; Confidence interval; Psoriasis; Internal medicine; Adverse effect; Randomized controlled trial; Biosimilar; Surgery; Dermatology; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.05762649998465511,"gpt":0.4055974419265284,"spread":0.3479709419418732,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001375459,0.0002848204,0.00252496,0.0002215909,0.0001461942,0.00001214561,0.001303231,0.0002309279,0.00001754833],"category_scores_gemma":[0.00036274,0.0001339234,0.0005131642,0.0002318917,0.001448872,0.00008506719,0.0001722741,0.0005996484,0.000001327207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003758103,"about_ca_system_score_gemma":0.00008609068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001254281,"about_ca_topic_score_gemma":0.00004570865,"domain_scores_codex":[0.9948334,0.002441415,0.001925932,0.0002759869,0.0001810358,0.0003423073],"domain_scores_gemma":[0.9949577,0.001003745,0.003239682,0.0005149355,0.0002046547,0.00007923777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8605986,0.01031948,0.1171276,0.00002543607,0.002429771,0.00001818527,0.001793903,0.00003661099,0.0005795819,0.00004404079,0.0005922294,0.006434632],"study_design_scores_gemma":[0.8825285,0.01081805,0.07451525,0.0002109509,0.002170638,0.0002057251,0.001977622,0.00005117786,0.02509986,0.0001551788,0.001918876,0.0003481541],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836332,0.0002193417,0.000119476,0.01391882,0.0002278988,0.001790365,0.00006301297,0.000002696045,0.00002523595],"genre_scores_gemma":[0.9972253,0.0002782112,0.001116152,0.001297336,0.00002759495,0.00002773987,0.000001050088,0.00001283089,0.00001376202],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0426123,"threshold_uncertainty_score":0.5461239,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2930875443","doi":"10.3389/fphar.2019.00279","title":"Biological Therapies in Immune-Mediated Inflammatory Diseases: Can Biosimilars Reduce Access Inequities?","year":2019,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":134,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Biosimilar; Medicine; Health care; Guideline; Quality (philosophy); Market access; Business; Intensive care medicine; Economic growth","retraction":null,"screen_n_in":null,"score":{"opus":0.07982178526645387,"gpt":0.3910443338224655,"spread":0.3112225485560116,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0009833663,0.0009812221,0.004352671,0.001380194,0.00009584943,0.00004310318,0.001876689,0.002550534,0.001431636],"category_scores_gemma":[0.0002530991,0.0007442472,0.0006907711,0.00107997,0.001227131,0.0001452316,0.0007646519,0.002356311,0.00009640738],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005509029,"about_ca_system_score_gemma":0.0007613194,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003033434,"about_ca_topic_score_gemma":0.00001271171,"domain_scores_codex":[0.9921703,0.003398032,0.001816936,0.001197874,0.00007807968,0.001338763],"domain_scores_gemma":[0.9976465,0.0009607368,0.0006952249,0.0005393868,0.00006040364,0.00009778077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008038009,0.001073972,0.009341775,0.008503116,0.003370625,0.0004134474,0.0002863824,0.000003174494,0.00101315,0.0001012536,0.1857155,0.7893739],"study_design_scores_gemma":[0.002011853,0.0001706357,0.0006320285,0.001441849,0.0007722751,0.00003182425,0.000127843,0.000005792352,0.0001324587,0.0001840588,0.9936084,0.0008809586],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003680576,0.9849228,0.00002137387,0.0005049383,0.01122267,0.001900641,0.0006900376,0.0001021394,0.0002673844],"genre_scores_gemma":[0.0002946469,0.9961367,0.0002037132,0.001367387,0.0001663118,0.0004969845,0.0006861379,0.0000812712,0.0005668606],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.807893,"threshold_uncertainty_score":0.9999453,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1424849964","doi":"10.2165/11593730-000000000-00000","title":"Biosimilars of Biological Drug Therapies","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":122,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Biosimilar; Risk analysis (engineering); Medicine; Immunogenicity; Drug; Pharmacology; Intensive care medicine; Immune system; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.1008791334877312,"gpt":0.349562527575078,"spread":0.2486833940873469,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006083546,0.0004615028,0.002169484,0.000176746,0.00006554337,0.000006749763,0.0006251435,0.00108232,0.002796092],"category_scores_gemma":[0.00007594813,0.0002654637,0.0009374591,0.0002694398,0.000759275,0.00002268068,0.0001994168,0.0005917846,0.0003382288],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002053202,"about_ca_system_score_gemma":0.00008606008,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001345338,"about_ca_topic_score_gemma":9.403302e-7,"domain_scores_codex":[0.9975621,0.0007977711,0.0007431851,0.0004721665,0.00002949576,0.0003953164],"domain_scores_gemma":[0.9985183,0.0004746768,0.0004128721,0.0005064698,0.00005574964,0.00003188365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001408567,0.0001223644,0.000005901209,0.001446119,0.0006606467,0.000001702544,0.0001583331,6.879328e-10,0.00003533225,0.002032902,0.01002031,0.9855023],"study_design_scores_gemma":[0.0001432333,0.00007865229,0.000004961193,0.001538267,0.0005150429,0.00001883481,0.00005544397,1.762412e-8,0.0003559539,0.0003893808,0.9965847,0.0003155109],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000007784657,0.9935172,0.00001054693,0.00006060616,0.0006700474,0.0003347086,0.0001976025,0.00005797233,0.00514351],"genre_scores_gemma":[0.00002850444,0.9966502,0.0006026501,0.0001712501,0.00004331748,0.00002846509,0.00008317368,0.00003039878,0.002362048],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9865644,"threshold_uncertainty_score":0.9999797,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3036912484","doi":"10.1038/s41557-020-0496-2","title":"Crowdsourcing drug discovery for pandemics","year":2020,"lang":"en","type":"article","venue":"Nature Chemistry","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":116,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Emera (Canada)","funders":"Wellcome Trust","keywords":"Chemistry; Drug discovery; Crowdsourcing; Pandemic; Coronavirus disease 2019 (COVID-19); Drug; Computational biology; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Data science; Nanotechnology; Pharmacology; Biochemistry; World Wide Web; Virology; Disease; Computer science; Infectious disease (medical specialty); Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01438503518534231,"gpt":0.2756163146335031,"spread":0.2612312794481608,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001226663,0.0001295663,0.0001985969,0.000005196917,0.00007846056,0.00001955351,0.0001973833,0.0006821244,0.0001172974],"category_scores_gemma":[0.0004385311,0.0001020585,0.0001402813,0.00007822377,0.0000896986,0.00004207693,0.0000624265,0.0007947558,0.00000675947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000148663,"about_ca_system_score_gemma":0.00002920139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":6.816824e-7,"about_ca_topic_score_gemma":2.565908e-7,"domain_scores_codex":[0.9993052,0.00001859178,0.000144929,0.0002808724,0.00002257761,0.0002277544],"domain_scores_gemma":[0.9995551,0.0001854207,0.00005214889,0.0001315296,0.00003992139,0.00003586292],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001120097,0.0000193528,0.0004510784,0.0001112863,0.0000689281,0.000001405934,0.00005046145,5.25064e-7,0.9536378,0.0001198875,0.04409447,0.001332797],"study_design_scores_gemma":[0.0004436882,0.00001108629,0.00005503991,0.00001366642,0.00004137261,0.000006801441,0.00007396034,0.00001353777,0.7826691,0.0001885963,0.2163592,0.0001238631],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8402318,0.04743836,0.01728565,0.06569537,0.002417834,0.0009520179,0.001025173,0.0006747774,0.02427896],"genre_scores_gemma":[0.986504,0.00003337847,0.001628846,0.005192024,0.0003017065,0.000008432922,0.00007715367,0.0000159942,0.006238435],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1722648,"threshold_uncertainty_score":0.5261168,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2070196919","doi":"10.1021/ac3018229","title":"Reusable Solid-Phase Microextraction Coating for Direct Immersion Whole-Blood Analysis and Extracted Blood Spot Sampling Coupled with Liquid Chromatography–Tandem Mass Spectrometry and Direct Analysis in Real Time–Tandem Mass Spectrometry","year":2012,"lang":"en","type":"article","venue":"Analytical Chemistry","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":115,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Waterloo","funders":"","keywords":"Chemistry; Chromatography; Solid-phase microextraction; Mass spectrometry; Detection limit; Tandem mass spectrometry; DART ion source; Dried blood spot; Whole blood; Analytical Chemistry (journal); Gas chromatography–mass spectrometry","retraction":null,"screen_n_in":null,"score":{"opus":0.0166881880134827,"gpt":0.3097533677512081,"spread":0.2930651797377254,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001615035,0.0005959476,0.001718713,0.000832481,0.0003261547,0.0001079502,0.0002206666,0.0008169999,0.0006251699],"category_scores_gemma":[0.0003527299,0.0005071061,0.0005709959,0.004035464,0.0004370111,0.0002374714,0.0000868447,0.0007283121,0.000004261019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001034053,"about_ca_system_score_gemma":0.00005287437,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009906121,"about_ca_topic_score_gemma":0.00002123411,"domain_scores_codex":[0.9964301,0.000193189,0.0009340954,0.001076652,0.0001856436,0.001180294],"domain_scores_gemma":[0.9973482,0.00127197,0.0004291721,0.0005170316,0.0001456401,0.000287961],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000710306,0.000727834,0.118467,0.00009419768,0.009966311,0.00001843699,0.00002606745,0.000008161723,0.869882,0.000009052428,0.00002433766,0.00006620067],"study_design_scores_gemma":[0.005423145,0.0007575674,0.03743931,0.0001124748,0.03868481,0.00009878157,0.0003410859,0.004238094,0.9117168,0.00003422306,0.000125165,0.001028529],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9852261,0.00241761,0.0100912,0.0001582598,0.00003827505,0.0002913456,0.0001431127,0.0001018252,0.001532306],"genre_scores_gemma":[0.9836095,0.0005369334,0.01443565,0.00004551879,0.0001207098,0.00002160578,0.0004239125,0.00004465229,0.0007615006],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08102774,"threshold_uncertainty_score":0.999738,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1989943185","doi":"10.1208/s12248-014-9696-2","title":"Workshop Report: Crystal City V—Quantitative Bioanalytical Method Validation and Implementation: The 2013 Revised FDA Guidance","year":2014,"lang":"en","type":"article","venue":"The AAPS Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":114,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institutes of Health; Agence Française de Sécurité Sanitaire des Produits de Santé; Health Canada; CHDI Foundation; Amgen; Pfizer; U.S. Food and Drug Administration; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Session (web analytics); Bioanalysis; Agency (philosophy); Library science; Plenary session; Medical education; Political science; Computer science; Engineering ethics; Medicine; Engineering; Nanotechnology; Sociology; World Wide Web","retraction":null,"screen_n_in":null,"score":{"opus":0.04574924758621939,"gpt":0.3867140678480431,"spread":0.3409648202618237,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006174891,0.0001633415,0.0002755917,0.00004787133,0.0007011682,0.0001247768,0.0002991082,0.0001293563,0.001164506],"category_scores_gemma":[0.0007777872,0.00007873026,0.0001345509,0.0002010378,0.0004617433,0.0001123974,0.0001166077,0.0006373413,0.00002183856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000261415,"about_ca_system_score_gemma":0.00004138026,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002278286,"about_ca_topic_score_gemma":0.00001656708,"domain_scores_codex":[0.9968788,0.001929468,0.0005571962,0.0002308191,0.00009704619,0.0003066485],"domain_scores_gemma":[0.9976488,0.001401154,0.0003896452,0.0003256267,0.0001872039,0.00004756641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001527582,0.0003587792,0.01308924,0.0000813748,0.004135901,0.00009536991,0.004007231,0.00007264008,0.1884021,0.1059546,0.4049497,0.2773255],"study_design_scores_gemma":[0.004953423,0.001094763,0.0481435,0.000247883,0.002382489,0.0147147,0.005296827,0.001788145,0.07138494,0.07500575,0.7738829,0.00110466],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.09654078,0.01224345,0.6817914,0.202887,0.002094013,0.0008946263,0.00004173031,0.0000765212,0.003430437],"genre_scores_gemma":[0.9326431,0.001216415,0.0574398,0.003534013,0.0006225641,0.00001816856,0.00002681194,0.00003259974,0.004466536],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.8361023,"threshold_uncertainty_score":0.9997486,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1586431308","doi":"10.1002/rcm.5182","title":"Pre‐cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact","year":2011,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":113,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Armand Frappier Museum","funders":"","keywords":"Dried blood spot; Chemistry; Hematocrit; Chromatography; Analyte; Spotting; Dried blood; Analytical Chemistry (journal); Artificial intelligence; Internal medicine; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.04836360972249332,"gpt":0.3466332403208914,"spread":0.2982696305983981,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001503356,0.0004960796,0.0008416165,0.00121302,0.0003152671,0.00006041668,0.003100677,0.0005281743,0.002496538],"category_scores_gemma":[0.0004692655,0.0004673125,0.0002752093,0.00207859,0.0004124751,0.0002601681,0.0009444569,0.001300462,0.0001745741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002075597,"about_ca_system_score_gemma":0.0001138245,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005430506,"about_ca_topic_score_gemma":0.0002128902,"domain_scores_codex":[0.9961375,0.001196291,0.0008654448,0.0007649903,0.000132852,0.0009029177],"domain_scores_gemma":[0.9949579,0.0005384297,0.0002199251,0.003879757,0.0001723016,0.000231687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004700385,0.003560872,0.008437427,0.00002838283,0.0009117611,0.00002294792,0.001842229,0.000003224996,0.9564227,0.02621388,0.0004260611,0.001660439],"study_design_scores_gemma":[0.001933843,0.002833729,0.03817241,0.000174595,0.0003659051,0.0002180889,0.0004520139,0.00003123749,0.9352249,0.01658929,0.003000013,0.001003951],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9403492,0.003047103,0.02056931,0.003472307,0.0004410389,0.003751545,0.0004209352,0.0005767915,0.02737179],"genre_scores_gemma":[0.8189766,0.0003837906,0.1791507,0.0004787203,0.00003729238,0.0003227668,0.00006493249,0.00005584826,0.0005293257],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1585813,"threshold_uncertainty_score":0.9997779,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2155591144","doi":"10.3390/ph5040353","title":"On the Regulatory Approval Pathway of Biosimilar Products","year":2012,"lang":"en","type":"article","venue":"Pharmaceuticals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":113,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Harmonization; Innovator; Scope (computer science); Medicine; Drug approval; Product (mathematics); Business; Risk analysis (engineering); Pharmacology; Computer science; Finance; Drug","retraction":null,"screen_n_in":null,"score":{"opus":0.0880573224176878,"gpt":0.3409084285292479,"spread":0.25285110611156,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001565004,0.0001590003,0.0002480995,0.00004512037,0.00009973322,0.000005113038,0.0002425614,0.0001700874,0.001728079],"category_scores_gemma":[0.0005237578,0.00008771672,0.0001041922,0.0001971262,0.0005382634,0.00004670607,0.00008727323,0.0003607023,0.0002455632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001478308,"about_ca_system_score_gemma":0.00002748688,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":8.279357e-7,"about_ca_topic_score_gemma":5.081249e-8,"domain_scores_codex":[0.9984848,0.0005012997,0.0002785396,0.0002041585,0.00006842653,0.0004628089],"domain_scores_gemma":[0.9987687,0.0006445884,0.00008432149,0.0003858047,0.00006489173,0.00005168631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001447181,0.000512983,0.0006895329,0.00004443842,0.0001900264,6.322417e-7,0.0001123691,2.35234e-7,0.8624097,0.1033589,0.0229554,0.009581039],"study_design_scores_gemma":[0.0002595812,0.00005212229,0.001306414,0.00001372293,0.00006069624,0.000009024304,0.00002884679,0.000004167842,0.8058739,0.0006180538,0.1916699,0.0001035448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8855742,0.0269147,0.000406125,0.03829128,0.004697758,0.001826063,0.0001756976,0.0002343921,0.04187977],"genre_scores_gemma":[0.9953024,0.00005425879,0.0003658685,0.003061006,0.000104925,0.00001566281,0.000003755206,0.00001358513,0.001078495],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1687145,"threshold_uncertainty_score":0.9991845,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2181230016","doi":"10.1111/cei.12742","title":"From the bench to clinical practice: understanding the challenges and uncertainties in immunogenicity testing for biopharmaceuticals","year":2015,"lang":"en","type":"review","venue":"Clinical & Experimental Immunology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":113,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services; University of Calgary; University of Alberta","funders":"","keywords":"Immunogenicity; Context (archaeology); Medicine; Clinical trial; Bench to bedside; Intensive care medicine; Risk analysis (engineering); Immunology; Biology; Medical physics; Pathology; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.605593475497232,"gpt":0.5769736681339371,"spread":0.02861980736329484,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.009068485,0.0006697857,0.002925512,0.00009011169,0.0003703112,0.00007104145,0.001215974,0.001922266,0.00007665846],"category_scores_gemma":[0.01117555,0.0003600154,0.0007540928,0.0002941845,0.002918757,0.00009272982,0.001318188,0.002479659,0.00008214896],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002704791,"about_ca_system_score_gemma":0.0003393611,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000132122,"about_ca_topic_score_gemma":0.00002250228,"domain_scores_codex":[0.988783,0.006357576,0.002715233,0.001224218,0.00009440157,0.0008255721],"domain_scores_gemma":[0.9541013,0.04404092,0.0007271379,0.0008858472,0.0001460827,0.00009870654],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007184066,0.0007684957,0.00004560422,0.0001506046,0.002311409,0.00001266261,0.0007237808,6.514855e-8,0.0001247668,0.005131795,0.001808748,0.9882036],"study_design_scores_gemma":[0.001643236,0.001677574,0.0001125927,0.001100202,0.001093124,0.00008922142,0.007948202,0.000003228313,0.00004466879,0.00214896,0.9836448,0.0004941855],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002465158,0.9893226,0.00007507644,0.004187044,0.003489025,0.002123299,0.000132953,0.00004819933,0.0003752805],"genre_scores_gemma":[0.001081334,0.9934964,0.00228137,0.002069799,0.0005367856,0.0003444219,0.00005090154,0.00006076286,0.0000782739],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9877095,"threshold_uncertainty_score":0.9998852,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2989858130","doi":"10.3389/fphar.2019.01372","title":"The Clinical Implications of Nocebo Effects for Biosimilar Therapy","year":2019,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":108,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Pfizer","keywords":"Nocebo Effect; Biosimilar; Nocebo; Medicine; Intensive care medicine; Psychosocial; Adverse effect; Disease; Psychological intervention; Rheumatoid arthritis; Alternative medicine; Pharmacology; Psychiatry; Immunology; Placebo; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1281461086588577,"gpt":0.4769020353471043,"spread":0.3487559266882466,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001710409,0.0003744127,0.002390202,0.000193244,0.0001308737,0.000007508841,0.0009193934,0.00131747,0.00005636259],"category_scores_gemma":[0.0002260895,0.0002224346,0.001009787,0.0003157463,0.0008469536,0.00002085759,0.0001231463,0.0008692231,0.00002349478],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006633477,"about_ca_system_score_gemma":0.0003123859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001390548,"about_ca_topic_score_gemma":9.245861e-7,"domain_scores_codex":[0.9958059,0.001839997,0.001228341,0.0005489705,0.00002570136,0.0005511034],"domain_scores_gemma":[0.9936361,0.005161873,0.0006160865,0.0004664345,0.00008597121,0.00003347652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001199228,0.0001500612,0.0001039618,0.001313791,0.001092487,4.983067e-7,0.000004241298,4.000126e-8,0.00007136459,0.0002268802,0.2455453,0.7513715],"study_design_scores_gemma":[0.001644808,0.0003930512,0.00004253339,0.0003057413,0.001227691,0.00000752339,0.000004421969,0.000002487938,0.0003686221,0.0006892723,0.9950867,0.000227152],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002660277,0.9805037,0.001481738,0.0008214021,0.01370082,0.003088866,0.0001843186,0.0000194688,0.0001970166],"genre_scores_gemma":[0.000005993765,0.9948836,0.002533607,0.0006742989,0.0001574575,0.000616829,0.00006598947,0.00004102735,0.001021182],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7511443,"threshold_uncertainty_score":0.999979,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3003887243","doi":"10.1007/s40265-020-01256-5","title":"The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":101,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Celltrion; Celltrion Healthcare","keywords":"Biosimilar; Medicine; Immune system; Pharmacotherapy; Intensive care medicine; Pharmacology; Immunology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02135709985174209,"gpt":0.3110286671542852,"spread":0.2896715673025431,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005286864,0.0005889109,0.002056237,0.00006743111,0.000373211,0.00004786149,0.001015477,0.001068764,0.0001307591],"category_scores_gemma":[0.0002422904,0.0003356839,0.001134516,0.0004700347,0.0006717459,0.00005098842,0.0005067048,0.001009224,0.0001891911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005229301,"about_ca_system_score_gemma":0.0002394032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002973072,"about_ca_topic_score_gemma":0.00000362828,"domain_scores_codex":[0.9968985,0.0007056186,0.001133815,0.000527452,0.0000935645,0.0006410172],"domain_scores_gemma":[0.9971312,0.001240581,0.0007367071,0.0007079872,0.000105982,0.00007750511],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003793531,0.00004189585,0.000008582299,0.002646159,0.000800694,0.000007312483,0.0001176947,4.687122e-8,0.00002845526,0.0004163711,0.003731831,0.992163],"study_design_scores_gemma":[0.000294786,0.00005201015,0.00004088667,0.002352366,0.0008367814,0.00001723588,0.0002887852,4.859996e-7,0.0001265229,0.00003627932,0.9955853,0.0003685768],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001512723,0.9952234,0.000001780869,0.0007417313,0.001606979,0.0005329862,0.001646876,0.00008675886,0.0001443536],"genre_scores_gemma":[0.00002039073,0.9987144,0.00005863754,0.0002319637,0.0002697801,0.0000544077,0.0003307932,0.00006024831,0.0002594012],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9918535,"threshold_uncertainty_score":0.9999095,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1997030467","doi":"10.1136/bmj.38797.635012.47","title":"Learning from the TGN1412 trial","year":2006,"lang":"en","type":"editorial","venue":"BMJ","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":101,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.02532472513244346,"gpt":0.3244561324852246,"spread":0.2991314073527812,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001076915,0.0002739585,0.0005150729,0.00002877153,0.0002355934,0.00004710483,0.0004874132,0.002334932,0.001368784],"category_scores_gemma":[0.002887599,0.0001595733,0.0002978015,0.00008553678,0.0002513295,0.00001809244,0.0001594212,0.00229705,0.0005215189],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003327883,"about_ca_system_score_gemma":0.0001656347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007213344,"about_ca_topic_score_gemma":0.00007818562,"domain_scores_codex":[0.9976625,0.001014103,0.000457608,0.0004118469,0.0001040104,0.0003499076],"domain_scores_gemma":[0.9948364,0.004372439,0.0002746369,0.0004164693,0.0000850514,0.00001500276],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003023129,0.00004124707,0.00001152248,0.000003788118,0.0002251158,0.000004702441,0.00001890833,4.663367e-7,0.0003148737,0.00002063404,0.9925166,0.003819048],"study_design_scores_gemma":[0.008934956,0.000268309,0.00003484918,0.00004179772,0.0002410857,8.635771e-7,0.00002264839,0.000001008828,0.0002635916,0.0002440792,0.989714,0.0002327571],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00009767617,0.002898386,0.00005695534,0.001657672,0.9858465,0.0004562451,0.0002375772,0.00007188626,0.008677121],"genre_scores_gemma":[0.0001528876,0.00008871368,0.0002389075,0.0001849523,0.9355986,0.00004027672,0.001309003,0.00003152072,0.0623551],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.05367798,"threshold_uncertainty_score":0.9995441,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156344403","doi":"10.1074/mcp.m112.022442","title":"Multiplexed Quantitation of Endogenous Proteins in Dried Blood Spots by Multiple Reaction Monitoring - Mass Spectrometry","year":2012,"lang":"en","type":"article","venue":"Molecular & Cellular Proteomics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":96,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Genome British Columbia; University of Victoria","funders":"","keywords":"Dried blood; Analyte; Chromatography; Chemistry; Selected reaction monitoring; Mass spectrometry; Dried blood spot; Biomarker discovery; Quantitative proteomics; Tandem mass spectrometry; Label-free quantification; Population; Small molecule; Whole blood; Multiplex; Sample preparation; Immunoassay; Blood sampling; Proteomics; Bioinformatics; Biochemistry; Biology; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02608756240591608,"gpt":0.2511941104659813,"spread":0.2251065480600652,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007600966,0.0002451693,0.0004080233,0.0002081491,0.00007581343,0.00001262258,0.0001930556,0.0004493594,0.00003094886],"category_scores_gemma":[0.000324847,0.0002463271,0.0001490015,0.0003618062,0.0001198262,0.0001198152,0.000057454,0.0004481375,0.00002097655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007852227,"about_ca_system_score_gemma":0.00003355577,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000183678,"about_ca_topic_score_gemma":0.00000277254,"domain_scores_codex":[0.9980848,0.0003977369,0.0005213183,0.0003308502,0.00009528476,0.0005700395],"domain_scores_gemma":[0.999194,0.00008403259,0.0002523511,0.0003479733,0.00006748526,0.00005415879],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001511175,0.000550287,0.01368668,0.00005983003,0.0001346536,0.00001219456,0.000148413,0.000004546568,0.9845923,0.0002007408,0.000004382979,0.0004548123],"study_design_scores_gemma":[0.001607737,0.0001727497,0.002115246,0.0000431359,0.00009827762,0.00001942473,0.0001162998,0.00002962025,0.9952408,0.0001198465,0.0001813254,0.0002555513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9791361,0.003559084,0.01557844,0.00004496134,0.0003691736,0.001080993,0.00002904508,0.00004233015,0.0001598611],"genre_scores_gemma":[0.9344335,0.00005424186,0.06520171,0.00001588618,0.00003884582,0.00007218589,0.00006673224,0.00003609942,0.00008081422],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04962328,"threshold_uncertainty_score":0.9999989,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2172721945","doi":"10.1074/mcp.o115.049957","title":"Multiple Reaction Monitoring Enables Precise Quantification of 97 Proteins in Dried Blood Spots","year":2015,"lang":"en","type":"article","venue":"Molecular & Cellular Proteomics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":94,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Genome British Columbia; University of Victoria","funders":"","keywords":"Dried blood; Spots; Chromatography; Chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.04297962943832009,"gpt":0.2689062182088691,"spread":0.225926588770549,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007629879,0.0001879544,0.0003286649,0.0001540455,0.00004582096,0.00001531876,0.0002131273,0.0004007478,0.000008167933],"category_scores_gemma":[0.0005291156,0.0001810942,0.0001013436,0.0002714101,0.0001272956,0.00007896199,0.00007710435,0.0003260153,0.00002439647],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005659106,"about_ca_system_score_gemma":0.00008813727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001902408,"about_ca_topic_score_gemma":0.000007929649,"domain_scores_codex":[0.998404,0.0003607735,0.0004717142,0.0003722109,0.00008463844,0.0003067115],"domain_scores_gemma":[0.9991107,0.0000506076,0.0002156579,0.0004262203,0.0001494154,0.00004737809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001803368,0.0003618383,0.004074797,0.00005930745,0.00006859122,0.00001888426,0.0001445249,0.00003203446,0.9923661,0.00029727,0.000006229619,0.002390041],"study_design_scores_gemma":[0.001501391,0.0001507014,0.001140469,0.0000858175,0.00007669651,0.000008341497,0.0001059522,0.0001058676,0.9950794,0.0007321848,0.0008212726,0.0001918792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9756882,0.001822835,0.02071976,0.0000955531,0.0003372862,0.001096873,0.000007707606,0.00003906169,0.0001927431],"genre_scores_gemma":[0.9738824,0.00003005269,0.02555056,0.00001525214,0.00002624903,0.0001022006,0.00002967589,0.00002574538,0.0003378601],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004830801,"threshold_uncertainty_score":0.7384806,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050903060","doi":"10.4155/bio.11.192","title":"2011 White Paper on Recent Issues in Bioanalysis and Regulatory Findings from Audits and Inspections","year":2011,"lang":"en","type":"article","venue":"Bioanalysis","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":93,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Canada; BioPhage Pharma (Canada)","funders":"U.S. Food and Drug Administration","keywords":"Bioanalysis; Excellence; White paper; Audit; Engineering ethics; Computer science; Political science; Nanotechnology; Business; Engineering; Accounting","retraction":null,"screen_n_in":null,"score":{"opus":0.03089835570510437,"gpt":0.2620523035579235,"spread":0.2311539478528191,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000418377,0.0002659652,0.0005753991,0.0005324913,0.0001716142,0.00002643143,0.0001512743,0.0003869426,0.006950005],"category_scores_gemma":[0.0001004114,0.0002092066,0.0001543779,0.0005690085,0.0004610141,0.0001078525,0.0001126178,0.0002911999,0.0001181264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004862272,"about_ca_system_score_gemma":0.00001575932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001675576,"about_ca_topic_score_gemma":0.00154526,"domain_scores_codex":[0.9982383,0.0002861361,0.0004253148,0.0006590221,0.0000648573,0.0003263571],"domain_scores_gemma":[0.9991986,0.0001316659,0.0001057661,0.0004283063,0.00006445593,0.00007116652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005200389,0.0009287056,0.8628662,0.00002567252,0.005425944,0.00003505617,0.002668107,0.000001288891,0.02581467,0.002900125,0.006379346,0.09243487],"study_design_scores_gemma":[0.000833621,0.000184636,0.9163269,0.0000394057,0.001325515,0.000005985795,0.0006928627,0.00002585844,0.01102728,0.001649826,0.06741644,0.0004716882],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9363018,0.05035034,0.00008446741,0.005933048,0.0004386284,0.0002640592,0.0001846131,0.0001260927,0.006316969],"genre_scores_gemma":[0.9827346,0.01029494,0.002296178,0.0007727101,0.00003645406,0.00001421455,0.00003853929,0.00001958226,0.003792794],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09196318,"threshold_uncertainty_score":0.9939578,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2139470111","doi":"10.4155/bio.09.108","title":"Incurred Sample Reproducibility: Views and Recommendations by the European Bioanalysis Forum","year":2009,"lang":"en","type":"article","venue":"Bioanalysis","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":90,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Bioanalysis; Sample (material); Safeguarding; Reproducibility; Computer science; Process (computing); Data science; Medicine; Chromatography; Chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.03759757155892282,"gpt":0.3136246980115632,"spread":0.2760271264526404,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003476344,0.0002591817,0.000506134,0.0001683032,0.0005314876,0.00008066509,0.0004010586,0.0001463427,0.0008988979],"category_scores_gemma":[0.001149847,0.0001595866,0.0003536621,0.00099015,0.000379346,0.0000867897,0.0001440747,0.0003015802,0.00006881385],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003423189,"about_ca_system_score_gemma":0.00001549499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000206162,"about_ca_topic_score_gemma":0.0001404623,"domain_scores_codex":[0.9962915,0.001575812,0.0006150017,0.001042284,0.00006477044,0.0004106717],"domain_scores_gemma":[0.997646,0.0004349861,0.000218974,0.001542061,0.00009711623,0.00006091154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002258968,0.000220766,0.004360099,0.000004126298,0.0009336115,0.000001031194,0.000111877,4.034196e-7,0.01002848,0.0004847686,0.04704575,0.9367865],"study_design_scores_gemma":[0.0004558568,0.0001431923,0.008160989,0.00001213547,0.001583159,0.00001210308,0.0005255981,0.00007476847,0.005052888,0.002094799,0.981526,0.0003584828],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.02606986,0.2341489,0.03393801,0.6583844,0.001461458,0.001830444,0.002297329,0.0007531194,0.04111643],"genre_scores_gemma":[0.9840834,0.001997932,0.004091328,0.004837028,0.00007037025,0.00001065651,0.0003794083,0.00002015461,0.0045097],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9580135,"threshold_uncertainty_score":0.9842302,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2342581896","doi":"10.1016/j.biologicals.2016.03.006","title":"Switching to biosimilar infliximab (CT-P13): Evidence of clinical safety, effectiveness and impact on public health","year":2016,"lang":"en","type":"review","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":84,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Infliximab; Medicine; Public health; Intensive care medicine; Internal medicine; Pathology; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.3128732576127962,"gpt":0.5311404830159735,"spread":0.2182672254031773,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01071663,0.0007517555,0.005522726,0.0002905662,0.0001881925,0.00003064981,0.0007185815,0.001158054,0.0003840498],"category_scores_gemma":[0.006730298,0.0003366931,0.001214043,0.0004370289,0.0005248542,0.00006236429,0.0005862455,0.0009222496,0.0001964044],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000166911,"about_ca_system_score_gemma":0.0004646553,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001931844,"about_ca_topic_score_gemma":0.000001091101,"domain_scores_codex":[0.9870169,0.008679417,0.002148275,0.001207638,0.00008271605,0.0008650573],"domain_scores_gemma":[0.9841385,0.01365395,0.001072498,0.0007450189,0.0001130595,0.0002769289],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002055774,0.0001997734,0.0003262357,0.002141949,0.0005525938,0.000005158191,0.000004400147,3.052936e-8,0.0002003982,0.0003969586,0.0004397119,0.9955272],"study_design_scores_gemma":[0.0005557043,0.004321209,0.005314175,0.02849856,0.0001745456,0.00007162812,0.00000366386,1.325943e-7,0.00007344166,0.0001361339,0.9603161,0.0005347115],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001012015,0.9948249,0.0003475022,0.001162961,0.0006212369,0.001499273,0.000354957,0.00006838168,0.0001087452],"genre_scores_gemma":[0.008792261,0.9897298,0.0003405392,0.0008653695,0.000114395,0.00005812127,0.00002214048,0.00003019204,0.00004715699],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9949925,"threshold_uncertainty_score":0.9999085,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2184990075","doi":"10.1002/dta.1927","title":"Quantitative determination of opioids in whole blood using fully automated dried blood spot desorption coupled to on‐line SPE‐LC‐MS/MS","year":2015,"lang":"en","type":"article","venue":"Drug Testing and Analysis","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":81,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"World Anti-Doping Agency; Partnership for Clean Competition","keywords":"Dried blood spot; Hydrocodone; Chromatography; Codeine; Whole blood; Oxycodone; Hydromorphone; Solid phase extraction; Matrix (chemical analysis); Extraction (chemistry); Medicine; Chemistry; Morphine; Opioid; Pharmacology; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.06849297977756455,"gpt":0.3416201090951506,"spread":0.2731271293175861,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001022348,0.0001742372,0.000521569,0.0005460867,0.00008116962,0.00002317473,0.0001054209,0.0001535687,0.00002170435],"category_scores_gemma":[0.001586629,0.0001502344,0.00009306119,0.001602469,0.0001256683,0.00005396266,0.0000557204,0.0001654065,0.000005914659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002450426,"about_ca_system_score_gemma":0.00004481839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006492797,"about_ca_topic_score_gemma":0.0001765853,"domain_scores_codex":[0.9985658,0.0003070284,0.0004612239,0.0003473188,0.00007254042,0.0002461182],"domain_scores_gemma":[0.9987583,0.0005424052,0.0002097788,0.0001745385,0.0002548781,0.00006010804],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0001997022,0.0006181068,0.06165801,0.00003913863,0.0007664456,0.00001936962,0.0007426625,0.002515512,0.9295818,0.0001068667,0.00002644239,0.003726006],"study_design_scores_gemma":[0.003807395,0.001605271,0.03516902,0.0003331279,0.005770526,0.0000301015,0.0009810062,0.7350701,0.2158998,0.0006835043,0.00003694237,0.000613149],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957985,0.0002315693,0.003385792,0.0002302182,0.00004435032,0.000116711,0.00003440106,0.00007620261,0.0000822048],"genre_scores_gemma":[0.9467796,0.000004735924,0.05288747,0.00007459338,0.00001383839,0.000003469074,0.00004533487,0.000009584152,0.0001813885],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7325546,"threshold_uncertainty_score":0.6126383,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2899941886","doi":"10.1111/apt.14997","title":"Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":81,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Robarts Clinical Trials; Western University","funders":"Allergan; Akebia Therapeutics; Janssen Pharmaceuticals; Ablynx","keywords":"Biosimilar; Medicine; Infliximab; MEDLINE; Intensive care medicine; Pharmacology; Internal medicine; Tumor necrosis factor alpha","retraction":null,"screen_n_in":null,"score":{"opus":0.06518226559974113,"gpt":0.3839225226909588,"spread":0.3187402570912177,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009935817,0.0006405496,0.003469844,0.0001648807,0.0001851398,0.00001090792,0.000457615,0.0007372036,0.0002036177],"category_scores_gemma":[0.000005769768,0.0004475656,0.0002327002,0.000215428,0.000638859,0.00006345808,0.0004043069,0.0007491689,0.00002730136],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006257294,"about_ca_system_score_gemma":0.00007027435,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000614994,"about_ca_topic_score_gemma":5.999175e-7,"domain_scores_codex":[0.9952256,0.001998103,0.001619594,0.0006275974,0.0000788252,0.0004502581],"domain_scores_gemma":[0.9969475,0.001462128,0.001014117,0.0003976134,0.0001103816,0.00006825101],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001843015,0.0005665764,0.0002457286,0.8166035,0.06995705,0.00000544266,0.0001597503,5.471207e-9,0.0006124628,0.00003004994,0.001378785,0.1102563],"study_design_scores_gemma":[0.002530552,0.001031352,0.00007006294,0.1770794,0.2319251,0.00004818565,0.00001512441,5.914164e-7,0.0007638845,0.00002727978,0.5856998,0.0008087229],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002152453,0.9962096,0.000008601751,0.0002095497,0.000449353,0.002484436,0.0003433867,0.00002994465,0.00004990041],"genre_scores_gemma":[0.000104989,0.9946312,0.0002088003,0.004582724,0.00005157882,0.00005464175,0.000254353,0.00004485681,0.00006688345],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6395241,"threshold_uncertainty_score":0.9997976,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2548570873","doi":"10.1016/s1470-2045(16)30312-6","title":"21st century pharmacovigilance: efforts, roles, and responsibilities","year":2016,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacovigilance; Biosimilar; Medicine; Agency (philosophy); Patient safety; Under-reporting; Business; Adverse effect; Pharmacology; Health care; Political science","retraction":null,"screen_n_in":null,"score":{"opus":0.08451045535989471,"gpt":0.4112558686540705,"spread":0.3267454132941758,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002352647,0.0004636403,0.002778049,0.000101369,0.0002154696,0.00002056554,0.0006672798,0.001120255,0.0009735405],"category_scores_gemma":[0.0002614888,0.0002126961,0.0003071393,0.0001398218,0.00121052,0.00003505042,0.0003985183,0.001088551,0.0003265632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001400029,"about_ca_system_score_gemma":0.0003193398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004911598,"about_ca_topic_score_gemma":0.000008326218,"domain_scores_codex":[0.9952571,0.002802488,0.0006055993,0.0005590733,0.0000461186,0.0007296129],"domain_scores_gemma":[0.9961235,0.002745235,0.0003620608,0.0006758789,0.00004674547,0.00004659979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001766266,0.00005009077,0.000006656649,0.001727365,0.0005225161,0.00001264438,0.00004095152,1.783393e-9,0.00006393489,0.007633544,0.02007676,0.9696889],"study_design_scores_gemma":[0.000782102,0.00020589,0.000006347567,0.001877956,0.0008135959,0.0003480802,0.00003835348,5.515898e-8,0.00003554572,0.0005212221,0.9950723,0.0002985345],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000009090669,0.984086,0.000005092745,0.001968736,0.001250047,0.0005822416,0.0003787988,0.00008413191,0.01163591],"genre_scores_gemma":[0.00000774653,0.9904805,0.000202528,0.001335026,0.0007237968,0.00009554048,0.00004486242,0.00003594018,0.007074045],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9749956,"threshold_uncertainty_score":0.9999397,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1968059729","doi":"10.1016/j.jpba.2008.03.028","title":"Blood sampling without blood draws for in vivo pharmacokinetic studies in rats","year":2008,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Waterloo; Memorial University of Newfoundland","funders":"","keywords":"Bioanalysis; In vivo; Chemistry; Solid-phase microextraction; Pharmacokinetics; Blood sampling; Sampling (signal processing); Chromatography; Sample preparation; Pharmacology; Computer science; Medicine; Biotechnology; Gas chromatography–mass spectrometry; Biology; Mass spectrometry","retraction":null,"screen_n_in":null,"score":{"opus":0.1265530067203569,"gpt":0.4295228783949239,"spread":0.3029698716745671,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001435858,0.0002250928,0.001090435,0.0008113836,0.000102157,0.00001012925,0.0002082902,0.0002449034,0.0004148689],"category_scores_gemma":[0.0003970778,0.0001438944,0.0003859393,0.001241102,0.001021913,0.00007431395,0.00008759777,0.000630299,0.000001554841],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002461145,"about_ca_system_score_gemma":0.00005750911,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009687201,"about_ca_topic_score_gemma":0.0000123717,"domain_scores_codex":[0.9977626,0.0002612177,0.00106715,0.0002994278,0.0001426399,0.0004670264],"domain_scores_gemma":[0.9986212,0.0007509488,0.0002225878,0.00008716913,0.0001527581,0.0001653315],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001309166,0.003074191,0.1047912,0.0002287701,0.01172609,0.0005494611,0.0005905002,0.00001420979,0.8658307,0.00009430398,0.0009018345,0.01088953],"study_design_scores_gemma":[0.04959563,0.003957279,0.03084106,0.0007655398,0.04825121,0.004009338,0.001403995,0.00323409,0.7453346,0.002621356,0.1081767,0.001809202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9759133,0.01975359,0.001077617,0.002693124,0.0003293244,0.0001616532,0.00002789733,0.000009013495,0.00003443551],"genre_scores_gemma":[0.9878196,0.007319065,0.003747523,0.0007032462,0.0001557557,0.000007418427,0.000003448749,0.000008882913,0.0002350562],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1204962,"threshold_uncertainty_score":0.5867842,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2126408079","doi":"10.1097/01.asn.0000140219.28618.9f","title":"Anti-Erythropoietin Antibody-Mediated Pure Red Cell Aplasia after Treatment with Recombinant Erythropoietin Products","year":2004,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":78,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Université Laval; St. John’s Health Sciences Centre; Princess Margaret Cancer Centre; University of Calgary; Ottawa Hospital; University Health Network; Ontario Institute for Cancer Research; McGill University Health Centre; University of Ottawa; Hospital for Sick Children; Queen's University","funders":"U.S. Food and Drug Administration","keywords":"Medicine; Pure red cell aplasia; Erythropoietin; Internal medicine; Kidney disease; Incidence (geometry); Pharmacokinetics; Gastroenterology; Anemia; Urology; Endocrinology; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.01048393502721091,"gpt":0.2591399298025255,"spread":0.2486559947753146,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0004840248,0.0003250057,0.001099412,0.00006358117,0.0001485251,0.000009895854,0.0003999319,0.0002473627,0.0001330448],"category_scores_gemma":[0.00004423802,0.0001715006,0.0005959335,0.0005590604,0.002947639,0.00006313534,0.0001074709,0.000607171,0.0000126633],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001383991,"about_ca_system_score_gemma":0.000321446,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009157991,"about_ca_topic_score_gemma":0.00001055393,"domain_scores_codex":[0.9978729,0.0004826776,0.0006873216,0.0003220153,0.000120972,0.0005140589],"domain_scores_gemma":[0.997527,0.0001749102,0.001479103,0.0004541652,0.000306952,0.00005788445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0017561,0.001297154,0.009980265,0.00004310294,0.001165364,0.00003198984,0.0006748294,0.00001737523,0.9645857,0.00001257832,0.01896996,0.00146562],"study_design_scores_gemma":[0.01399429,0.02793506,0.2552017,0.0002786555,0.001714085,0.003114541,0.00353991,0.000006843773,0.3704062,0.0005858136,0.3223472,0.0008757345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9458343,0.001760529,0.000191021,0.05144636,0.0004206556,0.0002500399,0.00002234912,0.00001513612,0.00005964646],"genre_scores_gemma":[0.9810238,0.002496973,0.01218405,0.003736089,0.000122451,0.000004951464,0.000006599679,0.00003192362,0.0003931546],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5941795,"threshold_uncertainty_score":0.9997658,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135773482","doi":"10.1093/ndt/gfu297","title":"Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS)","year":2014,"lang":"en","type":"article","venue":"Nephrology Dialysis Transplantation","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":77,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Pfizer; Cilag; Amgen","keywords":"Medicine; Darbepoetin alfa; Pure red cell aplasia; Incidence (geometry); Epoetin alfa; Internal medicine; Kidney disease; Surgery; Anemia","retraction":null,"screen_n_in":null,"score":{"opus":0.006396821213232355,"gpt":0.2469350739106032,"spread":0.2405382526973709,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001212343,0.000249168,0.0005734963,0.00009694632,0.0002336391,0.00001235752,0.0004201756,0.0006029479,0.0002701402],"category_scores_gemma":[0.0002205281,0.0001743761,0.0002257708,0.0004486588,0.0009203644,0.00007161922,0.00003276947,0.0004970814,0.00004731616],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002671175,"about_ca_system_score_gemma":0.0000531684,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001355899,"about_ca_topic_score_gemma":0.0002848422,"domain_scores_codex":[0.9971225,0.001358212,0.0005786304,0.0004708201,0.00009418134,0.0003756358],"domain_scores_gemma":[0.9976832,0.001213975,0.00040061,0.0004892556,0.000186636,0.00002638354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001074305,0.0001592018,0.07401959,0.00007021203,0.0003344617,0.000004220622,0.0004493381,0.0000252833,0.922224,0.0004340302,0.0004968226,0.000708468],"study_design_scores_gemma":[0.003104751,0.000546679,0.5963644,0.00003050997,0.0007542843,0.00009144301,0.0001309619,0.0001583011,0.3938745,0.0009509307,0.003623646,0.0003696705],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9828227,0.000963065,0.01124478,0.002289266,0.0003676218,0.0004273505,0.000153231,0.00008263794,0.001649381],"genre_scores_gemma":[0.9973155,0.001053028,0.0004934748,0.0005450621,0.00004982183,0.00002410729,0.0003670551,0.00001503153,0.0001369233],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5283496,"threshold_uncertainty_score":0.7110851,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1732176471","doi":"10.1016/s0065-230x(06)96010-2","title":"Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development: Quantification of Emerging Protein Biomarkers","year":2006,"lang":"en","type":"review","venue":"Advances in cancer research","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":77,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"American Association of Pharmaceutical Scientists","keywords":"Biomarker discovery; Drug development; Biomarker; Bioanalysis; Drug discovery; Proteomics; Computational biology; Identification (biology); Medicine; Bioinformatics; Drug; Biology; Pharmacology; Nanotechnology","retraction":null,"screen_n_in":null,"score":{"opus":0.4573813166261274,"gpt":0.6054037194228601,"spread":0.1480224027967327,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006128129,0.0003656248,0.001742342,0.0008828027,0.0001056759,0.00002135068,0.0005445521,0.0005186822,0.0001143962],"category_scores_gemma":[0.0005288888,0.0002782052,0.0002295437,0.001908838,0.0007595833,0.0002601278,0.000176764,0.001031552,0.000013709],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005846353,"about_ca_system_score_gemma":0.0007206757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002181763,"about_ca_topic_score_gemma":0.01425806,"domain_scores_codex":[0.9928628,0.003381452,0.00188493,0.0009875253,0.0002312886,0.0006519745],"domain_scores_gemma":[0.9964268,0.002555207,0.0003843797,0.0003967927,0.0002009312,0.00003595332],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002056988,0.0001847897,0.001285556,0.003726825,0.0004008762,0.000004328647,0.0001726752,0.000005844046,0.0004225327,0.00003189673,0.0004755764,0.9930834],"study_design_scores_gemma":[0.0004818575,0.00003895184,0.0006084896,0.01968949,0.00008554696,3.818932e-7,0.0001675026,0.000003971007,0.001606443,0.0002024273,0.9767683,0.0003466775],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007850659,0.9955448,0.0002738549,0.0003313439,0.0009127909,0.001730288,0.0002693991,0.00001240503,0.0001400797],"genre_scores_gemma":[0.000934593,0.9946163,0.002031094,0.00001355788,0.00007314701,0.001386021,0.0001248646,0.00003652494,0.0007839494],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9927367,"threshold_uncertainty_score":0.999967,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2185272193","doi":"10.4155/bio.15.226","title":"2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 3 – Lba, Biomarkers and Immunogenicity)","year":2015,"lang":"en","type":"article","venue":"Bioanalysis","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":74,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Health Canada; Genentech; Angelini Pharma; Bundesinstitut für Arzneimittel und Medizinprodukte; Amgen; Pfizer; U.S. Food and Drug Administration; Bristol-Myers Squibb; Eli Lilly and Company; Agence Nationale de Sécurité du Médicament et des Produits de Santé; Biogen","keywords":"Bioanalysis; Biopharmaceutical; Immunogenicity; Computer science; Nanotechnology; Medicine; Biotechnology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.03360566082740423,"gpt":0.2941366264752786,"spread":0.2605309656478743,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001228941,0.0005206344,0.0009655296,0.001244064,0.0001412084,0.00008964619,0.0003764864,0.0007440275,0.0003672856],"category_scores_gemma":[0.0006267567,0.0003873155,0.000248689,0.001940253,0.0007863593,0.0001328433,0.0002545792,0.0003973584,0.00008998137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001387686,"about_ca_system_score_gemma":0.00008243747,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001001398,"about_ca_topic_score_gemma":0.0008713178,"domain_scores_codex":[0.996938,0.0005117456,0.0007307391,0.001009675,0.0001610844,0.0006487509],"domain_scores_gemma":[0.9984787,0.0002317333,0.0002352457,0.0007905877,0.0001187052,0.0001450486],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002790569,0.0007771153,0.04681677,0.00003248313,0.01181607,0.00007074198,0.0003884001,0.000009848982,0.02026404,0.00112808,0.04622514,0.8696808],"study_design_scores_gemma":[0.007015497,0.002190443,0.01375453,0.0003054908,0.003573297,0.00005313722,0.007753562,0.0001627881,0.0667488,0.005487919,0.8908935,0.002061045],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.148418,0.6272829,0.0002236462,0.2054143,0.001548876,0.00154418,0.0002990142,0.0009763981,0.01429272],"genre_scores_gemma":[0.9409353,0.04473338,0.004617158,0.001523984,0.00009122991,0.00005527326,0.00009910887,0.00008220508,0.007862402],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.8676197,"threshold_uncertainty_score":0.9998579,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4214523030","doi":"10.3390/ph15030298","title":"A Sex- and Gender-Based Analysis of Adverse Drug Reactions: A Scoping Review of Pharmacovigilance Databases","year":2022,"lang":"en","type":"review","venue":"Pharmaceuticals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":72,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; University of Waterloo; University of British Columbia; British Columbia Centre of Excellence for Women's Health","funders":"","keywords":"Pharmacovigilance; Medicine; Adverse drug reaction; Drug reaction; Database; Drug; Adverse effect; Pharmacology; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.3252275046961626,"gpt":0.5177977323992277,"spread":0.1925702277030651,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002330397,0.0004080253,0.003666758,0.0005225858,0.00009861065,0.000002617845,0.0003451733,0.0001385698,0.01018452],"category_scores_gemma":[0.0006439852,0.0003234827,0.001036088,0.001540108,0.0004325102,0.00005437603,0.0002641787,0.0006853269,0.000007655135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004771767,"about_ca_system_score_gemma":0.0003174346,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001218051,"about_ca_topic_score_gemma":0.000001179498,"domain_scores_codex":[0.9952173,0.002155848,0.001549218,0.0006109322,0.0001241789,0.000342484],"domain_scores_gemma":[0.9949974,0.003371578,0.0009491523,0.0005391057,0.00006938972,0.00007335225],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004834672,0.0004010631,0.00004519849,0.6245559,0.008952705,0.00001118705,0.00001741657,0.000001349581,0.0003084374,0.0001671899,0.001149425,0.3643418],"study_design_scores_gemma":[0.0003163519,0.00001934116,0.000001084561,0.07889983,0.03796954,0.00001476099,0.000008633496,0.0000246056,0.0008890617,0.000003590995,0.8815735,0.0002796745],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002053746,0.9962494,0.0001597271,0.00005770668,0.0001841954,0.001131798,0.001695757,0.00002922346,0.000490115],"genre_scores_gemma":[0.00000928662,0.9975026,0.0007842058,0.0008015786,0.00001542428,0.0001590907,0.0005242586,0.00002512407,0.0001783798],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8804241,"threshold_uncertainty_score":0.9999217,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3215384357","doi":"10.1208/s12248-021-00649-y","title":"Anti-drug Antibody Validation Testing and Reporting Harmonization","year":2021,"lang":"en","type":"article","venue":"The AAPS Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":72,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pfizer (Canada); TransCanada (Canada)","funders":"","keywords":"Harmonization; Immunogenicity; Sample (material); Biotechnology; Computer science; Medicine; Chemistry; Biology; Chromatography; Antibody; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.07843213960607921,"gpt":0.3504298733020686,"spread":0.2719977336959894,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001651969,0.00007239462,0.0001603495,0.00002703101,0.0004562178,0.0000823907,0.00007124977,0.00006548397,0.0001811471],"category_scores_gemma":[0.002883544,0.00004412595,0.00004157638,0.000176963,0.00008911805,0.00007541598,0.00006451033,0.0003514312,0.000009104226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000967685,"about_ca_system_score_gemma":0.00004725117,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005554029,"about_ca_topic_score_gemma":5.505599e-7,"domain_scores_codex":[0.9988736,0.0003505181,0.0004600484,0.0001192117,0.00003363912,0.0001629819],"domain_scores_gemma":[0.9989005,0.0002481757,0.0005232055,0.0001121504,0.0001974663,0.00001853101],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000006608933,0.00002322161,0.04553179,0.000006517685,0.0000613752,0.00004191989,0.0001065855,0.00000667216,0.933384,0.0001425831,0.0009286328,0.0197601],"study_design_scores_gemma":[0.0006344608,0.00005244322,0.1620729,0.0001283556,0.0002064447,0.01159445,0.0004698567,0.0002175626,0.8122915,0.004060199,0.008067459,0.0002043747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862669,0.003056308,0.004709573,0.004246527,0.0005614479,0.00004729123,0.00000204256,0.0000229598,0.001086913],"genre_scores_gemma":[0.9926263,0.0002411807,0.005632838,0.0003461897,0.0001204579,3.481833e-7,0.000007280969,0.000007298372,0.001018109],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1210925,"threshold_uncertainty_score":0.3508905,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W76024419","doi":"10.1177/135965350701200114","title":"HIV-1 drug resistance surveillance using dried whole blood spots","year":2007,"lang":"en","type":"article","venue":"Antiviral Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AIDS Vancouver; Public Health Agency of Canada","funders":"","keywords":"Human immunodeficiency virus (HIV); Medicine; Drug resistance; Dried blood spot; Drug; Virology; Internal medicine; Pharmacology; Biology; Chemistry; Microbiology; Chromatography","retraction":null,"screen_n_in":null,"score":{"opus":0.02623441622039107,"gpt":0.298761823223603,"spread":0.2725274070032119,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001039477,0.0001987378,0.0003227824,0.00006926941,0.0001927027,0.00002109511,0.0002257108,0.0002143332,0.000181221],"category_scores_gemma":[0.00003449351,0.0001602035,0.0001319247,0.000269146,0.0002937507,0.00007464749,0.00003571721,0.0002698843,0.0001035373],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001470399,"about_ca_system_score_gemma":0.00002384814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001649332,"about_ca_topic_score_gemma":0.00005160903,"domain_scores_codex":[0.9985605,0.000234708,0.0002955989,0.0003465582,0.00004918114,0.0005134938],"domain_scores_gemma":[0.999296,0.0002075078,0.0001076571,0.000305576,0.00005877091,0.0000244924],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000539761,0.0001919043,0.02886957,0.000006915787,0.0001682975,0.00002822358,0.0001121367,1.393791e-7,0.9555542,0.0008068092,0.0040559,0.009666114],"study_design_scores_gemma":[0.001867299,0.00004793843,0.04860982,0.00003185341,0.00002037231,0.00001342139,0.00006120571,0.000002834694,0.66485,0.0006049786,0.2835356,0.0003547264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984665,0.006682695,0.001542549,0.001157991,0.0005708875,0.0001752306,0.0000355035,0.00009170588,0.005078482],"genre_scores_gemma":[0.9766661,0.0003220874,0.003036209,0.0006716581,0.00009104394,0.000001234941,0.00001595559,0.0000218598,0.01917387],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2907042,"threshold_uncertainty_score":0.6532911,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2900649681","doi":"10.1002/cpcy.53","title":"Flow Cytometry Method Validation Protocols","year":2018,"lang":"en","type":"article","venue":"Current Protocols in Cytometry","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Caprion (Canada)","funders":"","keywords":"Protocol (science); Computer science; Data validation; Data mining; Medical physics; Medicine; Database; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.09476345536470152,"gpt":0.4666930768652244,"spread":0.3719296215005229,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002820289,0.0004208291,0.0006624041,0.0009046389,0.0002077118,0.00009254854,0.0007353033,0.0005050387,0.002943602],"category_scores_gemma":[0.001021554,0.0003471593,0.0002088015,0.002307455,0.0004711737,0.0002503912,0.0003199147,0.0009056,0.0007960422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001909116,"about_ca_system_score_gemma":0.000135522,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005485796,"about_ca_topic_score_gemma":0.000003057508,"domain_scores_codex":[0.996154,0.001058119,0.0009078858,0.0008678106,0.0001773056,0.0008348606],"domain_scores_gemma":[0.9981571,0.0004016766,0.0002878263,0.000795403,0.0002707874,0.00008720593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009651217,0.001835983,0.08071384,0.0005607199,0.0001193072,0.000009983693,0.0001923185,0.000001821573,0.1210822,0.001258445,0.01541399,0.7778462],"study_design_scores_gemma":[0.003105148,0.0006817793,0.01237763,0.0007020219,0.00003133958,0.00003985357,0.00003683386,0.0003312251,0.4706711,0.001449061,0.509982,0.0005920482],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.003148224,0.0008300268,0.3281374,0.0007501677,0.002825486,0.653349,0.0002450274,0.0006783667,0.0100363],"genre_scores_gemma":[0.05111603,0.00001347497,0.08494596,0.0005718322,0.0009655313,0.8607014,0.0001061963,0.0001116884,0.001467929],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.7772542,"threshold_uncertainty_score":0.9999819,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3000625420","doi":"10.1007/s40744-019-00190-7","title":"Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?","year":2020,"lang":"en","type":"review","venue":"Rheumatology and Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":70,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"AbbVie","keywords":"Nocebo Effect; Biosimilar; Nocebo; Discontinuation; Medicine; Adverse effect; Intensive care medicine; Internal medicine; Alternative medicine; Placebo; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0174355441857241,"gpt":0.3083887121203034,"spread":0.2909531679345793,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006652876,0.0008233186,0.00317114,0.0002437987,0.0002588852,0.00001319788,0.0003311474,0.001275581,0.0001227443],"category_scores_gemma":[0.0001917194,0.0004079946,0.0002417744,0.0001691242,0.0006796285,0.00005297786,0.0002391231,0.000906606,0.00002453694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000486711,"about_ca_system_score_gemma":0.00007699712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003817294,"about_ca_topic_score_gemma":0.0002150208,"domain_scores_codex":[0.9947062,0.002678273,0.0008233452,0.001062427,0.0000520449,0.0006777245],"domain_scores_gemma":[0.9963916,0.002790749,0.0002866595,0.0003636064,0.00001420293,0.0001531748],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001536514,0.0001954226,0.09039634,0.00116188,0.002608052,0.0000922139,0.0009226011,3.408433e-8,0.00004545147,0.0005267357,0.0002209864,0.9022937],"study_design_scores_gemma":[0.005698574,0.002635692,0.001910288,0.003643229,0.0006373339,0.00159908,0.0001955019,0.000008114931,0.00008074304,0.0005979816,0.9823021,0.0006913985],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.125736,0.8687414,0.00006371157,0.003583083,0.000612452,0.001124155,0.000090543,0.00004390794,0.000004740333],"genre_scores_gemma":[0.02372099,0.9751985,0.0002112888,0.0005326216,0.00001314962,0.0002242617,0.00004214797,0.00004209264,0.00001494976],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9820811,"threshold_uncertainty_score":0.9998372,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2343568188","doi":"10.1038/nbt.3474","title":"Precision and robustness of 2D-NMR for structure assessment of filgrastim biosimilars","year":2016,"lang":"en","type":"letter","venue":"Nature Biotechnology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Canada","funders":"","keywords":"Biosimilar; Robustness (evolution); Medicine; Chemistry; Internal medicine; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01104029362711373,"gpt":0.3051033070369849,"spread":0.2940630134098712,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0003660513,0.0005028517,0.001330557,0.0005825133,0.00007772518,0.000006338846,0.0007059032,0.01976754,0.0002969049],"category_scores_gemma":[0.0004424678,0.0003270541,0.0002749622,0.0002711574,0.001376824,0.0000319405,0.0003281135,0.003986885,6.545793e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004809404,"about_ca_system_score_gemma":0.0001168867,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002126443,"about_ca_topic_score_gemma":0.000004219507,"domain_scores_codex":[0.9975914,0.0002056548,0.0006958365,0.0008419718,0.00009995042,0.0005652235],"domain_scores_gemma":[0.9972816,0.0009415327,0.0006896094,0.00078577,0.0002825514,0.00001892288],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001299401,0.00003876698,0.00006962174,0.0005703871,0.000568215,0.000005946883,0.000003648449,6.789168e-7,0.2755873,0.00112394,0.6883078,0.0335938],"study_design_scores_gemma":[0.001025012,0.0006528989,0.0002076579,0.0002780129,0.0003124964,0.00006407349,0.000007529099,0.00002199352,0.2703522,0.001775166,0.7249634,0.000339559],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"methods","genre_scores_codex":[0.00417793,0.01572985,0.0178202,0.9475241,0.004179444,0.00194549,0.0082773,0.0001723905,0.0001732571],"genre_scores_gemma":[0.2293879,0.007324534,0.3979501,0.3467547,0.005062647,0.000300319,0.004052237,0.0007128878,0.008454669],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.6007694,"threshold_uncertainty_score":0.9999182,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2774120458","doi":"10.4155/bio-2017-4974","title":"2017 White Paper on Recent Issues in Bioanalysis: A Global Perspective on Immunogenicity Guidelines &amp; Biomarker Assay Performance (Part 3 – Lba: Immunogenicity, Biomarkers and PK Assays)","year":2017,"lang":"en","type":"article","venue":"Bioanalysis","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Caprion (Canada); Health Canada; inVentiv Health Clinical","funders":"Health Canada; Genentech; Agence Nationale de Sécurité du Médicament et des Produits de Santé; Angelini Pharma; Sanofi; U.S. Food and Drug Administration; Bristol-Myers Squibb; Ministry of Health, Labour and Welfare; Pfizer; Amgen","keywords":"Bioanalysis; Immunogenicity; Biopharmaceutical; Excellence; Regulatory science; Biosimilar; Computer science; Nanotechnology; Chemistry; Political science; Medicine; Biotechnology; Biology; Chromatography","retraction":null,"screen_n_in":null,"score":{"opus":0.08757148376182888,"gpt":0.3844078216666881,"spread":0.2968363379048592,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003486048,0.0008677431,0.001495937,0.0006041084,0.001188758,0.0003276545,0.001272747,0.000894675,0.001671878],"category_scores_gemma":[0.00198855,0.0006697043,0.0007999687,0.0009735198,0.001335735,0.0003598947,0.0006073808,0.0005989614,0.000375314],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006756767,"about_ca_system_score_gemma":0.0001209812,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003807638,"about_ca_topic_score_gemma":0.003429205,"domain_scores_codex":[0.9945431,0.001137122,0.001306364,0.001631567,0.0003321081,0.001049722],"domain_scores_gemma":[0.995639,0.0002582426,0.0008139328,0.002421442,0.0007195714,0.0001477578],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009462532,0.003412316,0.5345663,0.0001347717,0.04078197,0.0001225454,0.0006001769,0.00005552544,0.05739892,0.002619721,0.05382958,0.2970156],"study_design_scores_gemma":[0.005241219,0.0007792802,0.6054751,0.0005262241,0.004081029,0.00008174621,0.001323552,0.0006104689,0.008158847,0.0006662992,0.3707253,0.002330907],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6645098,0.1691654,0.000276746,0.09892301,0.003584051,0.00187799,0.001669572,0.0004197962,0.05957366],"genre_scores_gemma":[0.9606473,0.02936316,0.002107054,0.001874311,0.0001508734,0.00006113277,0.0001377713,0.00005383306,0.005604606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3168957,"threshold_uncertainty_score":0.9995754,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2952089805","doi":"10.1111/bjd.18220","title":"<scp>AURIEL</scp> ‐PsO: a randomized, double‐blind phase <scp>III</scp> equivalence trial to demonstrate the clinical similarity of the proposed biosimilar <scp>MSB</scp> 11022 to reference adalimumab in patients with moderate‐to‐severe chronic plaque‐type psoriasis","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":65,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"Fresenius Kabi; Merck","keywords":"Biosimilar; Equivalence (formal languages); Medicine; Double blind; Similarity (geometry); Adalimumab; Mathematics; Computer science; Internal medicine; Artificial intelligence; Discrete mathematics; Disease; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03661824537907298,"gpt":0.3225131638699592,"spread":0.2858949184908862,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003347036,0.0006424203,0.002808069,0.0003741717,0.000350797,0.0001423011,0.001860835,0.001176754,0.00006221641],"category_scores_gemma":[0.005390784,0.0004283837,0.0006344426,0.001174231,0.001050786,0.0002821783,0.0005768954,0.002468423,0.00005789552],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001449189,"about_ca_system_score_gemma":0.001245429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001063856,"about_ca_topic_score_gemma":0.0003441524,"domain_scores_codex":[0.9903391,0.003974963,0.002982818,0.0009163643,0.0004721197,0.001314652],"domain_scores_gemma":[0.9908943,0.005255843,0.001553929,0.0008419132,0.001097511,0.0003564671],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8164873,0.0113051,0.03808125,0.0005585967,0.006400279,0.001124957,0.003245141,0.0007194097,0.01390181,0.001291111,0.08654119,0.02034383],"study_design_scores_gemma":[0.9109792,0.007395958,0.007944192,0.00126067,0.001101259,0.003894201,0.0009032013,0.00009819673,0.05236165,0.0006154227,0.01316539,0.0002807263],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887635,0.001989328,0.0005187858,0.001665949,0.002113359,0.004294319,0.0001822203,0.00002878109,0.0004438213],"genre_scores_gemma":[0.9954644,0.0005729523,0.001189937,0.002124912,0.0001439528,0.00005859232,0.00002078761,0.00005657623,0.0003678414],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09449181,"threshold_uncertainty_score":0.9998329,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2210363578","doi":"10.1016/s1470-2045(15)00381-2","title":"Postmarket policy considerations for biosimilar oncology drugs","year":2015,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Biosimilar; Context (archaeology); Authorization; Business; Marketing authorization; Competition (biology); Interchangeability; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.240915421907452,"gpt":0.4804593703366855,"spread":0.2395439484292335,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004796681,0.0006431379,0.004601309,0.0002842643,0.0004264329,0.00003508813,0.0009098881,0.002610071,0.0008454105],"category_scores_gemma":[0.00236323,0.0003742101,0.0007909953,0.0003980369,0.00120564,0.0000403315,0.0003844149,0.001419849,0.0004406415],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007656778,"about_ca_system_score_gemma":0.004231635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003812011,"about_ca_topic_score_gemma":0.00005735237,"domain_scores_codex":[0.9926233,0.004424925,0.001080475,0.0007003582,0.00006141521,0.001109483],"domain_scores_gemma":[0.9893931,0.008473861,0.0007344183,0.00100353,0.000296342,0.00009870868],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000124189,0.0001458921,2.104108e-7,0.0008357193,0.0007565073,0.000009183063,0.0001294523,7.448681e-8,0.00001282595,0.02057299,0.3544506,0.6229624],"study_design_scores_gemma":[0.001663195,0.001032491,6.305789e-7,0.0003438137,0.001974369,0.0006749211,0.00007628737,0.00000131915,0.00001429027,0.00851815,0.9852737,0.0004268185],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[3.571156e-7,0.9306762,0.00007306386,0.0340464,0.002109649,0.001893909,0.001237197,0.0001218156,0.02984145],"genre_scores_gemma":[0.000003760084,0.9793897,0.004257005,0.008932823,0.001882701,0.0006093778,0.0002866618,0.00007141024,0.004566547],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6308231,"threshold_uncertainty_score":0.999871,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2759477597","doi":"10.2147/ceor.s140063","title":"Drug tendering: drug supply and shortage implications for the uptake of biosimilars","year":2017,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"Pfizer","keywords":"Biosimilar; Procurement; Medicine; Economic shortage; Incentive; Health care; Business; Risk analysis (engineering); Pharmacology; Marketing; Economic growth","retraction":null,"screen_n_in":null,"score":{"opus":0.3883353871483248,"gpt":0.5507725914305369,"spread":0.1624372042822121,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004697052,0.0003276732,0.001843637,0.0002062824,0.0007309809,0.0001276865,0.0009233598,0.0005106698,0.00007922841],"category_scores_gemma":[0.0008714309,0.0001934196,0.0005962458,0.0000645949,0.001587056,0.00005032192,0.0006574728,0.0009168393,0.000009606202],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003283129,"about_ca_system_score_gemma":0.00027325,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000235249,"about_ca_topic_score_gemma":0.00007959033,"domain_scores_codex":[0.997403,0.000281046,0.001111687,0.0006443604,0.00003053887,0.000529324],"domain_scores_gemma":[0.9906827,0.007617261,0.0004219532,0.001072435,0.0001298947,0.00007577417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001474017,0.00004185119,0.001246138,0.001415309,0.0006233351,2.395772e-7,0.00003347529,1.677456e-8,0.000002493656,0.003300434,0.008085651,0.9852363],"study_design_scores_gemma":[0.0003642408,0.0000540837,0.004243573,0.0003499147,0.0004351274,0.00001021129,0.00008994409,0.000003905878,0.000007490733,0.001047278,0.9931921,0.0002021163],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001261999,0.9918718,0.00001595144,0.004568827,0.0004217075,0.001445958,0.00110455,0.000009836008,0.0004351621],"genre_scores_gemma":[0.000204851,0.99203,0.0005103744,0.0001556363,0.00005970371,0.0001980095,0.00005531219,0.00003937992,0.006746787],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9851065,"threshold_uncertainty_score":0.7887423,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2169181615","doi":"10.1002/cyto.b.20397","title":"African regional external quality assessment for CD4 T-cell enumeration: Development, outcomes, and performance of laboratories","year":2008,"lang":"en","type":"article","venue":"Cytometry Part B Clinical Cytometry","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"International Centre for Infectious Diseases","funders":"","keywords":"External quality assessment; Statistics; Standard deviation; Coefficient of variation; Human immunodeficiency virus (HIV); Cd4 t cell; Enumeration; Mathematics; Reproducibility; Medicine; Immunology; Combinatorics; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1583144928166233,"gpt":0.4228206829845942,"spread":0.2645061901679709,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002859446,0.0003046343,0.001007043,0.0002639117,0.000378564,0.00001958966,0.000312264,0.0005241158,0.0002608941],"category_scores_gemma":[0.0009334343,0.0002430943,0.0002406511,0.0008328481,0.001011823,0.0001440462,0.0001696982,0.0005374489,0.00002151016],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004939505,"about_ca_system_score_gemma":0.0003389018,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004462625,"about_ca_topic_score_gemma":0.000001896475,"domain_scores_codex":[0.9966981,0.00048108,0.001578321,0.0006023946,0.0001831093,0.0004569494],"domain_scores_gemma":[0.9960258,0.002520815,0.0005469801,0.0004125572,0.0003626232,0.0001312459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004603416,0.0006369363,0.9843392,0.0001377563,0.0002347998,0.000002492782,0.00005291251,1.474719e-7,0.006199345,0.000425752,0.001966771,0.005543514],"study_design_scores_gemma":[0.002532874,0.000802731,0.8929684,0.00003943102,0.00007418091,0.00002196169,0.00009267896,0.000008396504,0.03244958,0.00005905112,0.07057557,0.0003751133],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902735,0.001572114,0.00597981,0.0003281442,0.0008490813,0.0003146688,0.000107036,0.00005021163,0.0005254645],"genre_scores_gemma":[0.9585214,0.000471362,0.0381704,0.0006724785,0.0001297092,0.00003885127,0.00005433971,0.00002035208,0.001921095],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0913708,"threshold_uncertainty_score":0.9913096,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}